期刊
INTERNATIONAL JOURNAL OF PHARMACEUTICS
卷 386, 期 1-2, 页码 23-29出版社
ELSEVIER
DOI: 10.1016/j.ijpharm.2009.10.046
关键词
Praziquantel; Poly(epsilon-caprolactone); Cylindrical implant; Drug release; Scanning electron microscope
资金
- National Science and Technology Support Plan of Ministry of Health of China [2006BA106BO6]
- Shanghai Science and Technology Committee [08JC1411500]
- Shanghai Municipal Education Commission [09ZZ24]
Praziquantel (PZQ)-loaded poly(e-caprolactone) (PCL) cylindrical implants were fabricated and characterized. Implant diameter (3, 4 and 8 mm), drug loading (25% and 50%), and the end-capping were investigated to evaluate their effects on drug release. The evolution of implants with release time was conducted in terms of implant microstructure, crystallinity, drug content and molecular weight of PCL The results showed that drug release was fastest for the implant with a diameter of 3 mm and slowest for the implant with a diameter of 8 mm; drug release from the implant with a drug content of 50% was faster than that from the implant with a drug content of 25%; the release of PZQ from the end-capped implants was slightly slower than that from the corresponding end-uncapped implants. The effect of drug loadings on PZQ release was related with diameter of the implants and the effect was weakened as diameter of the implants increased. The drug release data for all the implants were best fitted with Ritger-Peppas model, therefore Fickian diffusion was the predominant release mechanism. The evolution of implants with release time verified that PZQ was gradually released from the exterior to the interior of the implants. (C) 2009 Elsevier B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据